---
aliases: /news/alembic-pharma-gets-usfda-nod-for-generic-drug-to-treat-breast-cancer
archetype: curated-content
author:
  - Athira Ravi
basePath: /news/
breadcrumbLinks:
  - /
  - /news/
  - ''
breadcrumbs:
  - Home
  - News
  - Alembic Pharma gets USFDA nod for generic drug to treat breast cancer
categories:
  - 'Symplur: Breast Cancer'
categorySlug:
  - 'symplur: breast cancer'
categoryUrl:
  - topic/symplur-breast-cancer
categoryLabel:
  - Breast Cancer
contentCategories: netspective-medigy-news-curated-content
institution: null
offering: null
layOut: single
date: '2022-12-27'
description: >-
  The approved injectable is therapeutically equal to AstraZeneca
  Pharmaceuticals LP's Faslodex Injection, which is a reference listed drug
  product (RLD). According to a statement from the firm, the US 
favIconImage: null
featuredImage:
  alt: Alembic Pharma gets USFDA nod for generic drug to treat breast cancer
  format: JPEG
  href: 75ff6898-e608-5353-a6ed-c4603a1c9895-featuredImage.jpeg
  size:
    - 300
    - 590
  valid: true
  workPackage: 16450
  wpAttachment:
    fileName: Curated_Featured_Image.png
    link: /api/v3/attachments/29891/content
featuredPdf: null
htmlMetaData:
  author: null
  description: null
  generator: null
  viewport: null
  articlemodified_time: null
  articlepublished_time: null
  msvalidate.01: null
  ogdescription: 'Alembic Pharma gets USFDA nod for generic drug to treat breast cancer    '
  ogimage: null
  ogsite_name: null
  ogtitle: Alembic Pharma gets USFDA nod for generic drug to treat breast cancer
  ogtype: null
  ogupdated_time: null
  ogurl: null
  yandex-verification: null
  robots: null
  fbapp_id: null
  oglocale: null
  fbadmins: null
  articlepublisher: null
  google-site-verification: null
  keywords: null
id: 16450
identifier: News
lastMod: '2022-12-27T22:14:38.811943Z'
link:
  brand: freepressjournal.in
  href: >-
    https://www.freepressjournal.in/business/alembic-pharma-gets-usfda-nod-for-generic-drug-to-treat-breast-cancer
  original: >-
    https://www.freepressjournal.in/business/alembic-pharma-gets-usfda-nod-for-generic-drug-to-treat-breast-cancer
href: >-
  https://www.freepressjournal.in/business/alembic-pharma-gets-usfda-nod-for-generic-drug-to-treat-breast-cancer
original: >-
  https://www.freepressjournal.in/business/alembic-pharma-gets-usfda-nod-for-generic-drug-to-treat-breast-cancer
mastHead: NEWS
mdName: 75ff6898-e608-5353-a6ed-c4603a1c9895.md
openGraphMetaData:
  ogdescription: 'Alembic Pharma gets USFDA nod for generic drug to treat breast cancer    '
  ogtitle: Alembic Pharma gets USFDA nod for generic drug to treat breast cancer
  ogurl: null
  ogimage: null
  ogsite_name: null
  ogtype: null
  ogupdated_time: null
  ogimageheight: null
openProjectCustomFields:
  cleanUrl: >-
    https://www.freepressjournal.in/business/alembic-pharma-gets-usfda-nod-for-generic-drug-to-treat-breast-cancer
  medigyTopics:
    - 'Symplur: Breast Cancer'
  sourceUrl: >-
    https://www.freepressjournal.in/business/alembic-pharma-gets-usfda-nod-for-generic-drug-to-treat-breast-cancer
openProjectWorkPackageType: Curated Content
searchCategory: News
slug: >-
  freepressjournal-alembic-pharma-gets-usfda-nod-for-generic-drug-to-treat-breast-cancer
source: open-project-curations
status: ''
sub: brief
tags:
  - News
title: Alembic Pharma gets USFDA nod for generic drug to treat breast cancer
via: ' '
insights_description: null
insights_name: null
viaLink: null
relatedOfferings: null
twitterMetaData:
  twittercard: null
  twitterdescription: 'Alembic Pharma gets USFDA nod for generic drug to treat breast cancer    '
  twittertitle: Alembic Pharma gets USFDA nod for generic drug to treat breast cancer
  twitterimage: null
  twitterurl: null
---
<p>The approved injectable is therapeutically equal to AstraZeneca Pharmaceuticals LP's Faslodex Injection, which is a reference listed drug product (RLD). According to a statement from the firm, the US Food &amp; Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA), Fulvestrant injectable, with a strength of 250 mg/5 mL (50 mg/mL) per single-dose prefilled syringe. The approved injectable is therapeutically equal to AstraZeneca Pharmaceuticals LP's Faslodex Injection, which is a reference listed drug product (RLD). According to the manufacturer, fulvestrant injection is an oestrogen receptor antagonist that can be used to treat breast cancer. The business, citing IQVIA data, estimated the market size for fulvestrant injection, 250 mg/5 mL, at USD 71 million for the twelve months ending September 2022. There are many different clinical trials that are being conducted in the field of breast cancer. These trials may be testing new treatments, such as drugs or therapies, or they may be evaluating different ways of delivering existing treatments to see if they are more effective. Some examples of clinical trials that may be relevant to breast cancer include:</p><ul><li>Phase 1 trials: These are the earliest stage of clinical trials and are usually small in size. They are designed to test the safety and dosage of a new treatment.</li><li>Phase 2 trials: These trials involve a larger group of people and are designed to evaluate the effectiveness of the treatment being tested.</li><li>Phase 3 trials: These are large, randomized controlled trials that compare the new treatment being tested to the current standard of care. They are designed to determine whether the new treatment is more effective than the current standard of care.</li><li>Phase 4 trials: These trials are conducted after a treatment has been approved by regulatory agencies and is being used in clinical practice. They are designed to monitor the long-term safety and effectiveness of the treatment.</li></ul><p>Some specific examples of clinical trials that are currently being conducted in the field of breast cancer include studies evaluating new chemotherapy regimens, targeted therapies, immunotherapies, and hormonal therapies. There are also clinical trials evaluating different types of surgery, such as breast-conserving surgery versus mastectomy, and different types of radiation therapy.</p>